A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma

A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma

<p>Abstract</p> <p>Background</p> <p>The primary objective of this study was to determine the maximum tolerated dose (MTD) of escalating doses of radiotherapy (RT) concomitantly with a fixed dose of gemcitabine (300 mg/m<sup>2</sup>/week) within the same ove...

Full description

Bibliographic Details
Main Authors: Aerts Raymond, Topal Baki, Van Steenbergen Werner, Van Cutsem Eric, Haustermans Karin, Budiharto Tom, Ectors Nadine, Bielen Didier, Vanbeckevoort Dirk, Goethals Laurence, Verslype Chris
Format: Article
Language:English
Published: BMC 2008-09-01
Series:Radiation Oncology
Online Access:http://www.ro-journal.com/content/3/1/30

Internet

http://www.ro-journal.com/content/3/1/30

Similar Items